Hepatitis Forums

Advanced Liver Disease Main Forums => Advanced Liver Disease => Topic started by: Hep Editors on January 15, 2020, 11:09:08 am

Title: Curing Hep C Linked to Improved Liver Cancer Survival
Post by: Hep Editors on January 15, 2020, 11:09:08 am
People with liver cancer who achieve a cure with direct-acting antiviral (DAA) therapy for hepatitis C have a lower rate of both liver-related and all-cause death over five years, according to research presented last week in Boston at The Liver Meeting, the annual meeting of the American Association for the Study of Liver Diseases (AASLD).

Long-term hepatitis C virus (HCV) infection can lead to liver cirrhosis (scarring), hepatocellular carcinoma (HCC, the most common type of liver cancer) and the need for a liver transplant. Studies have shown that hepatitis C treatment reduces the risk of developing liver cancer, and it may also improve outcomes among those who already have this malignancy.

Liver cancer is often detected late and is difficult to treat. At earlier stages, surgery to remove the cancer and local therapies to destroy tumors may be possible. HCC does not respond well to traditional chemotherapy. A variety of targeted therapies and immunotherapies are now approved for advanced liver cancer, but survival usually remains short.

For more...
https://www.hepmag.com/article/curing-hep-c-linked-improved-liver-cancer-survival